TCO Analysis
33 articles
Part D Formulary Tier Placement in 2026: How the Same Drug Costs $45 or $470 Before You Hit the $2,000 Out-of-Pocket Cap
Compare how three real Part D formularies price the same three-drug regimen in 2026, and see why formulary tier placement -- not the old donut hole -- determines whether you hit the $2,000 out-of-pocket cap in March or December.
Read more →Medicare Advantage $8,850 MOOP vs Medigap Plan G Near-Zero Out-of-Pocket: The 2026 Cost Math for an $85,000 Necrotizing Fasciitis Hospitalization
As federal cuts to public health surveillance raise the odds of serious infections like necrotizing fasciitis, here's the real 2026 dollar comparison between Medicare Advantage's out-of-pocket maximum and Medigap Plan G's near-zero cost-sharing.
Read more →$9,500/Month Nursing Home, $0 Medicare Coverage After Day 100: Original Medicare vs Medicare Advantage Dental, Hearing, and Long-Term Care Gaps for Sandwich Generation Families in 2026
Medicare pays $0 for nursing home care after day 100, $0 for dental, and $0 for hearing aids — gaps that can cost families $20,000–$50,000 in a single bad year. Here's what Original Medicare versus Medicare Advantage actually pays across each major coverage gap in 2026, with real dollar scenarios for sandwich generation families navigating both ACA plans and a parent's Medicare decisions.
Read more →Medicare Advantage's 95% SNF Denial Overturn Rate and Original Medicare's $0 Dental Coverage: The 2026 Out-of-Pocket Gap After ACA Subsidies Expired
A new OIG report found Medicare Advantage plans overturn 95% of SNF prior authorization denials on appeal. Combined with Original Medicare's $0 dental coverage and expired ACA subsidies, here's what the 2026 coverage gap actually costs you — with real dollar scenarios.
Read more →Medicare Advantage SNF Prior Authorization in 2026: OIG's 95% Denial Overturn Rate, ACA Enrollment Triggers, and the Part B Penalty Math for Adults Losing Federal Subsidies
A new OIG report finds Medicare Advantage plans overturn 95% of skilled nursing facility prior authorization denials — but the delays cost you while you wait. Here's how ACA subsidy expiration, Part D insulin pricing changes, and your enrollment window determine whether a 45-day SNF stay runs you $1,676 or $6,825 in 2026.
Read more →Medicare Advantage Part D Formulary Denials in 2026: The OIG's 95% Overturn Finding and What It Costs You While Waiting for Your Specialty Drug
A June 2026 OIG report found Medicare Advantage plans overturn 95% of SNF prior authorization denials on appeal — the same insurer machinery that controls your Part D drug access. Here's the out-of-pocket math when your plan says no.
Read more →Medicare Pays $0 for Dental, Vision, Hearing, and GLP-1 Drugs in 2026: Original Medicare vs Medicare Advantage Out-of-Pocket Cost Breakdown
Original Medicare covers $0 for dental, vision, hearing aids, and weight-loss drugs in 2026. Here's what Medicare Advantage actually pays — with real dollar comparisons — and how the new GLP-1 Bridge Program changes the math starting July 2026.
Read more →Medicare GLP-1 Bridge Program July 2026: Part D $2,000 Out-of-Pocket Cap vs Medicare Advantage Drug Costs — and the OIG Overpayment Warning That Changes the Math
The Medicare GLP-1 Bridge Program starts July 1, 2026, capping weight-loss drug costs at $2,000 annually under Part D — but only if your specific Medicare Advantage or standalone Part D plan opts in. Here's the full cost math before the window closes.
Read more →Medicare GLP-1 Bridge Program Starts July 2026: Which Enrollment Window Gets You Weight-Loss Drug Coverage — and the Part D Cost Math That Makes It Worth $14,000 Per Year
The Medicare GLP-1 Bridge Program launches July 2026, covering weight-loss drugs like Wegovy for the first time in Medicare history — but only if you're in a participating plan. Here's which enrollment window applies to you, the Part D cost math across Medicare Advantage vs Original Medicare, and the OIG warning that should shape your October plan decision.
Read more →Medicare Part D Formulary Trap in 2026: How Tier Changes, Prior Authorization, and the $2,000 OOP Cap Determine Whether You Pay $15 or $400 for the Same Medication
KFF data shows nearly 1 in 4 Medicare beneficiaries skip medications due to cost — here's how 2026 formulary tier changes, prior authorization rules, and the IRA's $2,000 cap interact to set your real annual drug bill.
Read more →Original Medicare Pays $0 for Dental, Vision, and Hearing in 2026: What a $3,200 Crown, $4,700 Hearing Aid, and $14,000 Skilled Nursing Stay Actually Cost You
Original Medicare covers $0 for dental, vision, and hearing — and stops covering skilled nursing after day 100. Here's what a $3,200 crown, $4,700 hearing aid, and 90-day nursing facility stay cost across Original Medicare, Medigap Plan G, and Medicare Advantage in 2026.
Read more →Medicare Pays $0 for Dental, Vision, and Hearing in 2026: Original Medicare vs Medicare Advantage Out-of-Pocket Costs for a $4,700 Hearing Aid and $2,500 Crown
Original Medicare covers $0 of routine dental, vision, and hearing care. Here's what you'll actually pay under Original Medicare, Medicare Advantage, and Medigap Plan G — with real dollar scenarios for a $4,700 hearing aid, a $2,500 crown, and a 10-year cost projection you need before your next enrollment period.
Read more →Medicare Part B $185/Month vs ACA $7,000 Deductible: MSP Cost Programs, Medigap Plan G, and the Enrollment Penalty Math for Adults Turning 65 in 2026
ACA deductibles hit record highs in 2026 as enhanced subsidies expire — and the cost math now strongly favors Medicare for most adults turning 65. Here's the side-by-side with real dollar amounts, IRMAA cliffs, and MSP programs that can cut your Part B premium to zero.
Read more →Medicare Part B Premium 2026: MSP Simplification Model Policies, CMS Hospice Enrollment Freeze, and Why TrumpRx Discounts Don't Count Toward Your $2,000 Out-of-Pocket Cap
Four Medicare policy shifts landed in May 2026 — from MSP enrollment reform to a CMS hospice freeze and the TrumpRx discount trap. Here's what each one means for your specific annual out-of-pocket cost.
Read more →Medicare Part B Over $200/Month in 2026: MSP Cost-Saving Programs, Prior Auth Delays, and the 4 Enrollment Windows That Determine Your Annual Bill
Part B premiums crossed $200/month in 2026 for the first time in Medicare history. Here's how Medicare Savings Programs, Extra Help, and choosing the right enrollment window can cut your annual costs by $2,400 or more — and why prior authorization delays could cost you regardless of which plan you chose.
Read more →Medicare Part D Drug Costs in 2026: Extra Help Income Limits, the $2,000 OOP Cap, and How Formulary Tier Placement Determines Your Real Prescription Bill
In 2026, Part B premiums crossed $200/month for the first time and Part D drug bills vary by thousands depending on formulary tier placement, zip code, and whether you qualify for Extra Help or a Medicare Savings Program. Here's the exact math for three income levels and one common three-drug regimen.
Read more →Pharmacy Discount Coupons vs Medicare Part D in 2026: Why TrumpRx Savings Don't Count Toward Your $590 Deductible or $2,000 Out-of-Pocket Cap
Using a TrumpRx or manufacturer coupon at the pharmacy feels like an easy win — until you realize those savings don't count toward your Part D deductible or $2,000 out-of-pocket cap, potentially costing you thousands more before December.
Read more →Medicare Part D Open Enrollment 2026: GLP-1 Bridge Program vs TrumpRx Coupons vs Plan Switch — The Drug Cost Math Before October 15
Medicare beneficiaries who want Wegovy or Zepbound have three paths before October 15: the new GLP-1 bridge program, TrumpRx pharmacy coupons, or switching Part D plans during open enrollment — and the 10-year cost difference can exceed $50,000.
Read more →Wegovy at $1,349/Month: TrumpRx Pharmacy Coupons vs the Medicare Part D Bridge Program — Which Actually Lowers Your Drug Bill in 2026
TrumpRx pharmacy coupons look like a deal on the surface — but for Medicare Part D enrollees, using them can quietly block your path to the $2,000 out-of-pocket cap. Here's the full cost breakdown for Wegovy, Ozempic, and GLP-1 weight loss drugs across every 2026 coverage option.
Read more →Medicare Savings Program Asset Test Blocks 6 Million Beneficiaries From Free Part B Premiums While Dental, Vision, and Hearing Gaps Cost $3,000–$9,000 Per Year in 2026
An AARP report finds 6 million Medicare beneficiaries qualify for Medicare Savings Programs but aren't enrolled — costing them $2,220/year in avoidable Part B premiums while Original Medicare's dental, vision, and hearing gaps add $3,000–$9,000 more per year. Here's the real cost breakdown by income level and plan type in 2026.
Read more →Medicare Advantage vs Medigap Plan G for a $6,700 ER Bill: What Your Open Enrollment Decision Actually Costs in an Emergency
A $6,700 emergency room bill for an allergic reaction reveals a $1,340 gap in out-of-pocket costs between Medicare Advantage and Medigap Plan G — and the enrollment window that determines which coverage you can access may already be closing.
Read more →Medigap Plan G at $178–$221/Month After IRMAA Surcharges: How the IRA's $2,000 Part D Cap Changes Whether Medicare Advantage Saves You Money in 2026
Medigap Plan G premiums jumped 12–15% in 2026 while IRMAA surcharges add up to $483/month on top of Part B. Here's the exact cost math — including the IRA's new $2,000 Part D out-of-pocket cap — that determines whether switching to Medicare Advantage actually saves you money.
Read more →Medigap Plan G at $178–$221/Month vs Medicare Advantage $0 Premium After the IRA's $2,000 Part D Cap: Which Costs Less for Specialty Drug Users in 2026
Medigap Plan G premiums are jumping 10–13% while the IRA's $2,000 Part D out-of-pocket cap reshapes drug cost math for specialty medication users. Here's the full dollar-by-dollar comparison before October Open Enrollment.
Read more →Medicare After Cancer Treatment in 2026: Part B CT Scan Coverage, Specialty Drug Bills, and the Dental and Hearing Gap That Could Cost You $6,000 More Per Year
Cancer survivors on Medicare face ongoing surveillance costs, specialty drug bills, and zero coverage for dental and hearing — gaps that add $4,000–$8,000 per year depending on your plan. Here's the exact cost breakdown across Original Medicare, Medigap Plan G, and Medicare Advantage in 2026.
Read more →Medicare Advantage $0 Premium vs Medigap Plan G $160/Month: True Annual Cost After Hospitalization, Skilled Nursing Copays, and IRMAA Surcharges in 2026
A $0-premium Medicare Advantage plan looks like a bargain — until you're hospitalized for five days or need 30 days of skilled nursing. Here's the real annual cost comparison, including IRMAA surcharges, for 2026.
Read more →CMS 2027 Final Part C and D Rule: Medicare Advantage Benchmark Pay Increases, Relaxed Marketing Rules, and the Part D Drug Cost Math You Need Before October Open Enrollment
CMS just finalized the 2027 Medicare Advantage and Part D rule — raising benchmark payments and loosening marketing restrictions. Here's what higher plan pay and relaxed sales rules actually mean for your premiums, drug costs, and whether to stay put or switch before fall open enrollment.
Read more →Medicare Doesn't Cover GLP-1 Weight Loss Drugs, Dental, Vision, Hearing, or Long-Term Care in 2026: The Out-of-Pocket Cost Breakdown Across Original Medicare and Medicare Advantage
Medicare has five major coverage gaps — dental, vision, hearing, long-term care, and GLP-1 weight loss drugs — that cost beneficiaries thousands per year. Here's the real dollar breakdown across Original Medicare and Medicare Advantage plans in 2026, with a worked example for each gap.
Read more →Medicare Part A $1,676 Deductible vs Medicare Advantage MOOP in 2026: How IRMAA Surcharges, Rural Facility Closures, and Denial Rates Determine Your Real Out-of-Pocket Cost
Original Medicare's $1,676 Part A deductible and uncapped cost-sharing look manageable—until you add IRMAA surcharges, a rural network gap, or a prior auth denial. Here's the full 2026 cost picture and a worked example showing why two beneficiaries on the same plan type can owe $5,400 apart by December.
Read more →Medicare Part D Prior Authorization Delays in 2026: New CMS Drug Approval Deadlines, What They Cost You While Waiting, and How to Pick the Right Plan
CMS is proposing 24-hour urgent and 72-hour standard prior authorization deadlines for Part D drugs — but until the rule takes effect, approval delays are costing Medicare beneficiaries $1,200–$2,800 per year in out-of-pocket drug spending that never counts toward the $2,000 OOP cap. Here is how to evaluate your plan before October 15.
Read more →Part D Tier 2 to Tier 3 Formulary Change: How Medicare Advantage Prior Authorization Denials Add $2,400+ to Your Drug Costs in 2026
When your Medicare Advantage plan silently moves your medication from Tier 2 to Tier 3 and adds a prior authorization requirement, your annual drug bill can jump by $2,400 or more — and the out-of-pocket cap won't protect you during the denial gap. Here's the math.
Read more →ACA Marketplace Premium at $847/Month After Subsidies Expire vs Medicare Part B at $185: Enrollment Deadlines and Lifetime Penalty Math for Adults Turning 65 in 2026
Enhanced ACA subsidies expired in December 2025, pushing silver plan premiums above $800/month for adults 63–64. Here's the exact Medicare enrollment window, the lifetime penalty math if you miss it, and how your income determines which plan actually costs less over 10 years.
Read more →Ozempic vs. Wegovy on Medicare Part D in 2026: Formulary Tiers, the $2,000 OOP Cap, and Why Your Coverage Depends on Your Diagnosis
Medicare Part D covers Ozempic for diabetes but excludes Wegovy for weight loss — and the cost difference is up to $14,000 a year. Here's the exact math across every coverage phase.
Read more →Medicare Advantage $0 Premium vs Medigap Plan G $150/Month: The 10-Year Out-of-Pocket Cost Comparison Before March 31
Before the Medicare Advantage Open Enrollment Period closes March 31, run the real 10-year numbers: a $0-premium MA plan vs Medigap Plan G has a break-even point most people never calculate—and IRMAA surcharges change the math entirely above $106,000 income.
Read more →